FDA warning letter cites cybersecurity gaps in a VirtuOst VFA cloud migration as grounds for a new 510(k)
FDA sent O.N. Diagnostics a warning letter dated September 1 over an uncleared update to VirtuOst VFA, the vertebral fracture assessment software cleared under 510(k) K171435, after version 3.0.0 added a new machine learning model and moved the software from a desktop application to a web based architecture that FDA said introduced network exposed attack surfaces and authentication vulnerabilities.